logo
episode-header-image
Oct 2008
16m 43s

7. Breast cancer

SURGERY 101 TEAM
About this episode
In this episode, Dr Parveen Boora discusses breast cancer. Topics covered include: approach to the history and physical exam of breast masses indications for breast imaging and biopsy staging invasive cancer management of breast cancer surgery for primary tumors surgery for axillary tumors post-operative therapy Run time - 16:42 
Up next
Nov 19
433. Arterial Ulcers and Diabetic Foot Ulcers
After listening to this podcast, learners will be able to: <!-- [if !supportLists]-->● <!--[endif]-->Describe the important features of medical history related to arterial ulcers and diabetic foot ulcers <!-- [if !supportLists]-->● <!--[endif]-->Recognize the important physical e ... Show More
17m 31s
Nov 12
432. Chronic Wound Care Principles and Venous Ulcers
After listening to his podcast, learners will be able to: ● List four wound prep principles and five patient related factors for caring for patients with chronic wounds ● Describe the important features of the medical history related to venous ulcers ● Recognize the important phy ... Show More
16m 35s
Nov 12
432. Chronic Wound Care Principles and Venous Ulcers NOTES
Description: PDF Notes for Surgery 101 episode on Chronic Wound Care Principles and Venous Ulcers 
Recommended Episodes
Nov 2023
#278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.
<p><a href= "https://peterattiamd.com/haroldburstein/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=231106-pod-haroldburstein&utm_content=231106-pod-haroldburstein-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subscri ... Show More
2h 10m
Apr 2023
Journal Review in Breast Surgery: Management of Hereditary Breast Cancer
While you are likely aware of BRCA mutations as a significant risk factor for development of breast cancer (60-80% lifetime risk), there are many other pathogenic gene variants that have been identified in recent years. The surgical treatment of women with hereditary breast cance ... Show More
41m 48s
Sep 2022
Breast Cancer Risk
Dr. Manisha Bahl summarizes major take home points from "Mammographic Breast Density, Benign Breast Disease, and Subsequent Breast Cancer Risk in 3.9 Million Korean Women" by Dr. Soyeoun Kim and colleagues.  Mammographic Breast Density, Benign Breast Disease, and Subsequent Breas ... Show More
10m 42s
Mar 2020
Breast Cancer Surgery
Dr. Jeanine Cook-Garard talks about breast cancer surgeries and a program called the Hidden Scar. Our guest today is Dr. Shubhada Dhage, Associate Director of the Breast Health Program at NYU Winthrop Hospital and their Director of Breast Surgical Services. 
29m 53s
Nov 2023
Hereditary Breast Cancer, Genetic Testing, and Therapeutic Implications
Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991258). The topics and discussions ... Show More
19m 26s
May 2024
Ep. 172 HPV and Oropharyngeal Cancer: Evolving Insights and Implications with Dr. Mihir Patel
In this episode, Dr. Mihir Patel, Professor of Otolaryngology at Emory University and expert in Transoral Robotic Surgery (TORS), discusses HPV-positive head and neck cancer with host Dr. Ashley Agan. --- CHECK OUT OUR SPONSOR Medtronic ENT https://www.medtronic.com/en-us/healthc ... Show More
1h 6m
Apr 2022
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update
An interview with Dr. Fabrice André from Institute Gustave Roussy in Paris, France, and Dr. Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, NY, authors on “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Updat ... Show More
9m 36s
Jul 2014
Screening for Breast Cancer
Switzerland looks set to be the first country in Europe to halt routine breast screening; yet in the UK a review of the same evidence came to the opposite conclusion. Dr Mark Porter asks how two groups of experts can arrive at such different decisions, and examines the harms and ... Show More
28 m